Literature DB >> 15982448

Positive association of AKT1 haplotype to Japanese methamphetamine use disorder.

Masashi Ikeda1, Nakao Iwata, Tatsuyo Suzuki, Tsuyoshi Kitajima, Yoshio Yamanouchi, Yoko Kinoshiya, Yoshimoto Sekine, Masaomi Iyo, Mutsuo Harano, Tokutaro Komiyama, Mitsuhiko Yamada, Ichiro Sora, Hiroshi Ujike, Toshiya Inada, Norio Ozaki.   

Abstract

Recent evidence suggests that the AKT1-GSK3beta signalling cascade partially mediates dopamine-dependent behaviours. In relation to the pathophysiology of schizophrenia or methamphetamine (Meth) use disorder, AKT1 is a good candidate gene for such conditions. For schizophrenia, positive associations of SNPs and AKT1 haplotypes were reported in US and Japanese samples. To evaluate the association between AKT1 and Meth-use disorder, we conducted a case-control study of Japanese samples (182 patients and 437 controls). A positive association between a SNP and haplotypes was found, and the 'signal' SNP was the same SNP found to be associated with US schizophrenia, but not with Japanese schizophrenia. Our results indicate that AKT1 may play a possible role in the development of Meth-use disorder. Further investigation of these associations, together with evidence from previous animal studies, may open the way to elucidation of the pathophysiology of this condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982448     DOI: 10.1017/S1461145705005481

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  15 in total

Review 1.  Insulin signaling and addiction.

Authors:  Lynette C Daws; Malcolm J Avison; Sabrina D Robertson; Kevin D Niswender; Aurelio Galli; Christine Saunders
Journal:  Neuropharmacology       Date:  2011-03-21       Impact factor: 5.250

Review 2.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

3.  Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence.

Authors:  Chad A Bousman; Stephen J Glatt; Mariana Cherner; J Hampton Atkinson; Igor Grant; Ming T Tsuang; Ian P Everall
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

4.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

Review 5.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

6.  A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.

Authors:  Yi-Wen Chen; Hui-Yun Kao; Ming-Yuan Min; Wen-Sung Lai
Journal:  Schizophr Bull       Date:  2013-03-08       Impact factor: 9.306

Review 7.  Biological treatments for amfetamine dependence : recent progress.

Authors:  Kevin P Hill; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Cocaine regulates protein kinase B and glycogen synthase kinase-3 activity in selective regions of rat brain.

Authors:  Shane A Perrine; Jonathon S Miller; Ellen M Unterwald
Journal:  J Neurochem       Date:  2008-08-20       Impact factor: 5.372

9.  No Association Between AKT1 Polymorphisms and Methamphetamine Addiction in Iranian Population.

Authors:  Soudeh Ghafouri-Fard; Iman Azari; Fatemeh Hashemian; Azim Nejatizadeh; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2019-10-25       Impact factor: 3.444

Review 10.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.